By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Insert Therapeutics Inc. 

2585 Nina Street

Pasadena  California  91107  U.S.A.
Phone: 626-683-7200 Fax: 626-683-7220


SEARCH JOBS








Company News
Arrowhead Nanobiotechnology Subsidiaries, Calando Pharmaceuticals, Inc. and Insert Therapeutics Inc., Complete Merger 4/24/2008 9:03:46 AM
Insert Therapeutics Inc. to Initiate a Multinational Phase II Clinical Trial of Lead Drug Candidate IT-101 in Ovarian Cancer 4/17/2008 10:34:22 AM
Arrowhead Research Corporation (ARWR) Streamlines Business Model of Nanobiotech Subs, Calando Pharmaceuticals, Inc. and Insert Therapeutics Inc. 2/28/2008 8:59:19 AM
Calando Pharmaceuticals, Inc. and Insert Therapeutics Inc. Appoint Larry Stambaugh as CEO and President 10/31/2007 8:06:54 AM
Insert Therapeutics Inc.'s Lead Anti-Cancer Compound is Highlighted in Public Television Documentary 10/9/2007 12:25:59 PM
Arrowhead Research Corporation (ARWR) Subsidiary, Insert Therapeutics Inc., Awarded Patent for Cyclosert(TM) Camptothecin, the Company's Lead Oncology Candidate 9/24/2007 10:11:02 AM
Arrowhead Research Corporation (ARWR) Subsidiary, Insert Therapeutics Inc., Publishes Interim Phase I Data from Human Clinical Trials for New Cancer Drug 6/1/2007 1:11:32 PM
Arrowhead Research Corporation (ARWR) Subsidiary, Insert Therapeutics Inc., to Present at Institutional Investor Conference 5/17/2007 1:02:59 PM
Arrowhead Research Corporation (ARWR) Subsidiary, Insert Therapeutics Inc., to Present at NSTI Nanotech 07 Conference 5/17/2007 12:57:22 PM
Arrowhead Research Corporation (ARWR) Subsidiaries Insert Therapeutics Inc. & Calando Pharmaceuticals, Inc. Present Data on Cyclosert(TM) Drug Delivery System at American Association for Cancer Research Meeting 4/16/2007 11:56:05 AM
12
//-->